AURA BIOSCIENCES INC (AURA) Stock Analyst Earnings Estimates
NASDAQ:AURA - Nasdaq - US05153U1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 301.74% | N/A 98.27% | N/A 90.56% | N/A 131.09% | N/A 54.55% | ||||||
| EBITDA YoY % growth | -23.63M | -21.38M 9.52% | -34.42M -60.99% | -59.12M -71.76% | -83.696M -41.57% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.14M | -22.21M 8.00% | -35.25M -58.71% | -60.3M -71.06% | -84.991M -40.95% | N/A -10.75% | N/A -18.01% | N/A -16.79% | N/A -11.14% | N/A 35.59% | N/A 78.64% | N/A 647.81% | N/A 451.95% | N/A 74.71% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.99 55.76% | -1.98 0.50% | N/A 13.69% | N/A -22.52% | N/A 0.10% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 19.22% | -0.48 -19.77% | -0.50 -21.74% | -0.50 -19.49% | -0.54 -18.83% | -0.60 -25.83% | -0.45 10.49% | -0.47 6.30% | -0.49 8.35% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.458M 1.31% | -26.01M -16.57% | -26.877M -18.08% | -29.172M -25.57% | -26.826M -9.68% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.42 12.50% | -0.45 | 0.03 | 6.54% |
| Q2 2024 Q2Q % growth | -0.41 14.58% | -0.46 | 0.05 | 10.68% |
| Q1 2024 Q2Q % growth | -0.40 13.04% | -0.50 | 0.10 | 19.34% |
| Q4 2023 Q2Q % growth | -0.56 -1.82% | -0.42 | -0.14 | -33.19% |
| Q3 2023 Q2Q % growth | -0.48 11.11% | -0.53 | 0.05 | 9.64% |
| Q2 2023 Q2Q % growth | -0.48 -4.35% | -0.50 | 0.02 | 3.88% |
| Q1 2023 Q2Q % growth | -0.46 -4.55% | -0.55 | 0.09 | 16.54% |
| Q4 2022 Q2Q % growth | -0.55 78.09% | -0.53 | -0.02 | -3.20% |
| Q3 2022 Q2Q % growth | -0.54 98.09% | -0.52 | -0.02 | -4.58% |
| Q2 2022 Q2Q % growth | -0.46 | -0.47 | 0.01 | 2.81% |
| Q1 2022 Q2Q % growth | -0.44 | -0.45 | 0.01 | 1.40% |
| Q4 2021 Q2Q % growth | -2.51 | -0.40 | -2.11 | -525.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.41% | 12.52% | 0% | 2.71% |
| Revenue | N/A | N/A | N/A | N/A |